BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 22329609)

  • 1. Narrowband ultraviolet B phototherapy in childhood vitiligo: evaluation of results in 28 patients.
    Percivalle S; Piccinno R; Caccialanza M; Forti S
    Pediatr Dermatol; 2012; 29(2):160-5. PubMed ID: 22329609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Narrowband UVB phototherapy in vitiligo: evaluation of results in 53 patients.
    Percivalle S; Piccino R; Caccialanza M; Forti S
    G Ital Dermatol Venereol; 2008 Feb; 143(1):9-14. PubMed ID: 18833047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the effect of disease duration in generalized vitiligo on its clinical response to narrowband ultraviolet B phototherapy.
    Hallaji Z; Ghiasi M; Eisazadeh A; Damavandi MR
    Photodermatol Photoimmunol Photomed; 2012 Jun; 28(3):115-9. PubMed ID: 22548391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo.
    Stinco G; Piccirillo F; Forcione M; Valent F; Patrone P
    Eur J Dermatol; 2009; 19(6):588-93. PubMed ID: 19651562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted broadband ultraviolet b phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: a randomized, double-blind study.
    Asawanonda P; Kijluakiat J; Korkij W; Sindhupak W
    Acta Derm Venereol; 2008; 88(4):376-81. PubMed ID: 18709309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective study of narrowband-UVB phototherapy for treatment of vitiligo in Malaysian patients.
    Adauwiyah J; Suraiya HH
    Med J Malaysia; 2010 Dec; 65(4):297-9. PubMed ID: 21901949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the effects of NB-UVB in both segmental and non-segmental vitiligo affecting different body sites.
    Anbar TS; Westerhof W; Abdel-Rahman AT; El-Khayyat MA
    Photodermatol Photoimmunol Photomed; 2006 Jun; 22(3):157-63. PubMed ID: 16719871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy.
    Brazzelli V; Antoninetti M; Palazzini S; Barbagallo T; De Silvestri A; Borroni G
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1369-74. PubMed ID: 17958843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of vitiligo with broadband ultraviolet B and vitamins.
    Don P; Iuga A; Dacko A; Hardick K
    Int J Dermatol; 2006 Jan; 45(1):63-5. PubMed ID: 16426381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Narrow-band UVB for the treatment of generalized vitiligo in children.
    Kanwar AJ; Dogra S
    Clin Exp Dermatol; 2005 Jul; 30(4):332-6. PubMed ID: 15953060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo.
    Scherschun L; Kim JJ; Lim HW
    J Am Acad Dermatol; 2001 Jun; 44(6):999-1003. PubMed ID: 11369913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic evaluation of UVB-targeted phototherapy in vitiligo that affects less than 10% of the body surface area.
    Welsh O; Herz-Ruelas ME; Gómez M; Ocampo-Candiani J
    Int J Dermatol; 2009 May; 48(5):529-34. PubMed ID: 19416388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted ultraviolet B phototherapy in vitiligo: A comparison between once-weekly and twice-weekly treatment regimens.
    Majid I; Imran S
    Indian J Dermatol Venereol Leprol; 2015; 81(6):600-5. PubMed ID: 26515839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narrowband UVB therapy for vitiligo: does the repigmentation last?
    Sitek JC; Loeb M; Ronnevig JR
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):891-6. PubMed ID: 17658996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo.
    Hartmann A; Lurz C; Hamm H; Bröcker EB; Hofmann UB
    Int J Dermatol; 2005 Sep; 44(9):736-42. PubMed ID: 16135141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study.
    Casacci M; Thomas P; Pacifico A; Bonnevalle A; Paro Vidolin A; Leone G
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):956-63. PubMed ID: 17659006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
    Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M
    Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients.
    Fai D; Cassano N; Vena GA
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):916-20. PubMed ID: 17659000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Useful treatment of vitiligo in 10 children with UV-B narrowband (311 nm).
    Brazzelli V; Prestinari F; Castello M; Bellani E; Roveda E; Barbagallo T; Borroni G
    Pediatr Dermatol; 2005; 22(3):257-61. PubMed ID: 15916579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo.
    Arca E; Taştan HB; Erbil AH; Sezer E; Koç E; Kurumlu Z
    J Dermatol; 2006 May; 33(5):338-43. PubMed ID: 16700666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.